Rabat – Italian pharmaceutical and nutraceutical company PharmaNutra has signed a new agreement to bring its health products to Morocco. This makes Morocco one of the latest countries, including Bahrain and Peru, to welcome PharmaNutra’s supplements and medical devices.
The distribution agreement in Morocco was signed last September with Alcantara Pharmaceuticals. Registration is now underway for three of PharmaNutra’s products: SiderAL, SiderAL Gocce, and Apportal, said PharmaNutra in a press release.
These products are expected to be available starting next year “in what is considered one of the leading economies in Africa,” added the statement.
After signing the new contracts in Morocco, Bahrain, and Peru, the pharmaceutical company has expanded its presence to reach 88 foreign countries.
“These are important numbers, achieved in just over ten years of international activity by the Group, making them even more meaningful,” said Carlo Volpi, CEO of PharmaNutra.
“It’s clear that the key difference lies in the scientific value of our products, the result of extraordinary work by our Research & Development department,” Volpi added.
The expansion is part of PharmaNutra’s strategy to grow its presence worldwide while continuing to focus on quality, science, and innovation, said the company.
PharmaNutra specializes in iron-based supplements and medical products that help with muscle and joint health.
The company was founded in 2003 by Andrea and Roberto Lacorte.
